Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma

Genomic Imprinting Testing for Diagnosis of Bladder Cancer

NCT03563443 ·Status: UNKNOWN

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

NCT04718948 ·Status: UNKNOWN

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

NCT05070039 ·Status: COMPLETED ·Phase: NA

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

NCT06193941 ·Status: COMPLETED

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

NCT07036731 ·Status: RECRUITING ·Phase: NA

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

NCT06289283 ·Status: ACTIVE_NOT_RECRUITING

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

NCT06087016 ·Status: RECRUITING

PENK Methylation Test for Detecting Bladder Cancer

NCT05220189 ·Status: RECRUITING

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

NCT00244205 ·Status: UNKNOWN

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

NCT04625556 ·Status: RECRUITING

Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

NCT06679920 ·Status: RECRUITING ·Phase: NA

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

NCT03591367 ·Status: COMPLETED ·Phase: NA

Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup

NCT06153849 ·Status: NOT_YET_RECRUITING

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

NCT04432909 ·Status: UNKNOWN

Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder

NCT05077852 ·Status: UNKNOWN

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

NCT00867620 ·Status: UNKNOWN

Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer

NCT06775977 ·Status: RECRUITING

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

NCT02745301 ·Status: COMPLETED

A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

NCT06991868 ·Status: RECRUITING

BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma

NCT02278978 ·Status: UNKNOWN ·Phase: PHASE2

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

NCT05052372 ·Status: TERMINATED

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

NCT03673202 ·Status: UNKNOWN

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

NCT06870253 ·Status: ACTIVE_NOT_RECRUITING